M Vella1, M D Alexander2, M C Mabray3, D L Cooke4, M R Amans4, C M Glastonbury5, H Kim6,7, M W Wilson8, D E Langston4,6, M B Conrad8,6, S W Hetts9,6. 1. From the Departments of Radiology and Biomedical Imaging (M.V.). 2. Department of Radiology, Division of Interventional Neuroradiology (M.D.A.), University of Utah, Salt Lake City, Utah. 3. Department of Radiology, Division of Neuroradiology (M.C.M.), University of New Mexico, Albuquerque, New Mexico. 4. Division of Neurointerventional Radiology (D.L.C., M.R.A., D.E.L., S.W.H.). 5. Division of Diagnostic Neuroradiology (C.M.G.). 6. Hereditary Hemorrhagic Telangiectasia Center of Excellence (H.K., D.E.L., M.B.C., S.W.H.). 7. Anesthesia and Perioperative Care (H.K.), University of California, San Francisco, San Francisco, California. 8. Division of Interventional Radiology (M.W.W., M.B.C.). 9. Division of Neurointerventional Radiology (D.L.C., M.R.A., D.E.L., S.W.H.) steven.hetts@ucsf.edu.
Abstract
BACKGROUND AND PURPOSE: Patients with hereditary hemorrhagic telangiectasia (HHT) have a high prevalence of brain vascular malformations, putting them at risk for brain hemorrhage and other complications. Our aim was to evaluate the relative utility of MR imaging and MRA compared with DSA in detecting cerebral AVMs in the HHT population. MATERIALS AND METHODS: Of 343 consecutive patients evaluated at the University of California, San Francisco HTT Center of Excellence, 63 met the study inclusion criteria: definite or probable hereditary hemorrhagic telangiectasia defined by meeting at least 2 Curacao criteria or positive genetic testing, as well as having at least 1 brain MR imaging and 1 DSA. MRIs were retrospectively reviewed, and the number of AVMs identified was compared with the number of AVMs identified on DSA. RESULTS: Of 63 patients, 45 (71%) had AVMs on DSA with a total of 92 AVMs identified. Of those, 24 (26%) were seen only on DSA; 68 (74%), on both DSA and MR imaging; and 5 additional lesions were seen only on MR imaging. Of the 92 lesions confirmed on DSA, 49 (53.3%) were seen on the 3D-T1 postgadolinium sequence, 52 (56.5%) were seen on the 2D-T1 postgadolinium sequence, 35 (38.0%) were seen on the SWI sequence, 24 (26.1%) were seen on T2 sequence, and 25 (27.2%) were seen on MRA. The sensitivity and specificity of MR imaging as a whole in detecting AVMs then confirmed on DSA were 80.0% and 94.4%, respectively, and the positive and negative predictive values were 97.3% and 65.4%, respectively. CONCLUSIONS: This study reinforces the use of MR imaging as a primary screening tool for cerebral AVMs in patients with hereditary hemorrhagic telangiectasia and suggests that 3D-T1 postgadolinium and 2D-T1 postgadolinium performed at 3T are the highest yield sequences.
BACKGROUND AND PURPOSE:Patients with hereditary hemorrhagic telangiectasia (HHT) have a high prevalence of brain vascular malformations, putting them at risk for brain hemorrhage and other complications. Our aim was to evaluate the relative utility of MR imaging and MRA compared with DSA in detecting cerebral AVMs in the HHT population. MATERIALS AND METHODS: Of 343 consecutive patients evaluated at the University of California, San Francisco HTT Center of Excellence, 63 met the study inclusion criteria: definite or probable hereditary hemorrhagic telangiectasia defined by meeting at least 2 Curacao criteria or positive genetic testing, as well as having at least 1 brain MR imaging and 1 DSA. MRIs were retrospectively reviewed, and the number of AVMs identified was compared with the number of AVMs identified on DSA. RESULTS: Of 63 patients, 45 (71%) had AVMs on DSA with a total of 92 AVMs identified. Of those, 24 (26%) were seen only on DSA; 68 (74%), on both DSA and MR imaging; and 5 additional lesions were seen only on MR imaging. Of the 92 lesions confirmed on DSA, 49 (53.3%) were seen on the 3D-T1 postgadolinium sequence, 52 (56.5%) were seen on the 2D-T1 postgadolinium sequence, 35 (38.0%) were seen on the SWI sequence, 24 (26.1%) were seen on T2 sequence, and 25 (27.2%) were seen on MRA. The sensitivity and specificity of MR imaging as a whole in detecting AVMs then confirmed on DSA were 80.0% and 94.4%, respectively, and the positive and negative predictive values were 97.3% and 65.4%, respectively. CONCLUSIONS: This study reinforces the use of MR imaging as a primary screening tool for cerebral AVMs in patients with hereditary hemorrhagic telangiectasia and suggests that 3D-T1 postgadolinium and 2D-T1 postgadolinium performed at 3T are the highest yield sequences.
Authors: Yi Guo; Tara Saunders; Hua Su; Helen Kim; Deniz Akkoc; David A Saloner; Steven W Hetts; Christopher Hess; Michael T Lawton; Andrew W Bollen; Tony Pourmohamad; Charles E McCulloch; Tarik Tihan; William L Young Journal: Stroke Date: 2012-02-02 Impact factor: 7.914
Authors: Waleed Brinjikji; Vivek N Iyer; Giuseppe Lanzino; Kent R Thielen; Christopher P Wood Journal: J Neurointerv Surg Date: 2016-02-26 Impact factor: 5.836
Authors: R K Fulbright; J C Chaloupka; C M Putman; G K Sze; M M Merriam; G K Lee; P B Fayad; I A Awad; R I White Journal: AJNR Am J Neuroradiol Date: 1998-03 Impact factor: 3.825
Authors: T Krings; H Kim; S Power; J Nelson; M E Faughnan; W L Young; K G terBrugge Journal: AJNR Am J Neuroradiol Date: 2015-01-08 Impact factor: 3.825
Authors: A J Easey; G M F Wallace; J M B Hughes; J E Jackson; W J Taylor; C L Shovlin Journal: J Neurol Neurosurg Psychiatry Date: 2003-06 Impact factor: 10.154
Authors: Wuyang Yang; Ann Liu; Alice L Hung; Maria Braileanu; Joanna Y Wang; Justin M Caplan; Geoffrey P Colby; Alexander L Coon; Rafael J Tamargo; Edward S Ahn; Judy Huang Journal: Neurosurgery Date: 2016-05 Impact factor: 4.654